Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000503911 | SCV000596189 | likely benign | not specified | 2017-03-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000960420 | SCV001813370 | likely benign | not provided | 2019-08-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002056862 | SCV002458994 | likely benign | Schuurs-Hoeijmakers syndrome | 2024-12-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002446979 | SCV002734489 | likely benign | Inborn genetic diseases | 2017-07-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000960420 | SCV004136961 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | PACS1: BP4, BP7 |
Prevention |
RCV003925480 | SCV004739369 | likely benign | PACS1-related disorder | 2024-01-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |